CRISPR AND THETREATMENT/EN DISTINCTION : On Vagueness, Borderline Cases and Germline Genome Editing
In this thesis, I argue that the treatment/enhancement distinction that is central to the ethical debate concerning germline genome editing and CRISPR is too vague to be ethically and normatively guiding. The problem of vagueness is twofold, being both a semantic and epistemic issue. This vagueness...
Main Author: | Svensson, Ellen |
---|---|
Format: | Others |
Language: | English |
Published: |
Umeå universitet, Institutionen för idé- och samhällsstudier
2021
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-184615 |
Similar Items
-
CRISPR-Cas9 Germline Editing: Full Steam Ahead to Revolutionary Profit or Revolutionary Public Medicine?
by: Yuka Sai
Published: (2018-11-01) -
The Dubious Benefits of Germline Editing
by: Jennifer Gumer
Published: (2018-09-01) -
Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis
by: Alix Lenia v. Hammerstein, et al.
Published: (2019-11-01) -
Vagueness and Borderline Cases
by: Daly, Helen
Published: (2011) -
Gene editing in translational research
by: Marc Güell
Published: (2019-11-01)